Annual Total Debt
$101.38 M
+$7.55 M+8.04%
31 December 2023
Summary:
BioXcel Therapeutics annual total debt is currently $101.38 million, with the most recent change of +$7.55 million (+8.04%) on 31 December 2023. During the last 3 years, it has risen by +$99.99 million (+7152.07%). BTAI annual total debt is now at all-time high.BTAI Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$104.97 M
+$1.71 M+1.65%
30 September 2024
Summary:
BioXcel Therapeutics quarterly total debt is currently $104.97 million, with the most recent change of +$1.71 million (+1.65%) on 30 September 2024. Over the past year, it has increased by +$5.35 million (+5.37%). BTAI quarterly total debt is now at all-time high.BTAI Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTAI Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.0% | +5.4% |
| 3 y3 years | +7152.1% | +7055.4% |
| 5 y5 years | +100.0% | +9701.0% |
BTAI Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +9075.0% | at high | +9399.5% |
| 5 y | 5 years | at high | at high | >+9999.0% | |
| alltime | all time | at high | at high |
BioXcel Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $104.97 M(+1.7%) |
| June 2024 | - | $103.26 M(+1.3%) |
| Mar 2024 | - | $101.98 M(+0.6%) |
| Dec 2023 | $101.38 M(+8.0%) | $101.38 M(+1.8%) |
| Sept 2023 | - | $99.62 M(+1.9%) |
| June 2023 | - | $97.80 M(+1.8%) |
| Mar 2023 | - | $96.09 M(+2.4%) |
| Dec 2022 | $93.84 M(+8392.0%) | $93.84 M(+1.0%) |
| Sept 2022 | - | $92.88 M(+49.0%) |
| June 2022 | - | $62.33 M(+4597.1%) |
| Mar 2022 | - | $1.33 M(+20.1%) |
| Dec 2021 | $1.10 M(-21.0%) | $1.10 M(-24.7%) |
| Sept 2021 | - | $1.47 M(+16.9%) |
| June 2021 | - | $1.25 M(-5.5%) |
| Mar 2021 | - | $1.33 M(-5.0%) |
| Dec 2020 | $1.40 M | $1.40 M(-4.7%) |
| Sept 2020 | - | $1.47 M(+61.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $907.00 K(-5.6%) |
| Mar 2020 | - | $961.00 K(-6.6%) |
| Dec 2019 | $1.03 M(>+9900.0%) | $1.03 M(-3.9%) |
| Sept 2019 | - | $1.07 M(-3.7%) |
| June 2019 | - | $1.11 M(-3.6%) |
| Mar 2019 | - | $1.15 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $371.00 K(>+9900.0%) | $371.00 K(>+9900.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00 |
| Dec 2016 | $0.00(-100.0%) | - |
| July 2016 | $1.77 M(-25.3%) | - |
| July 2015 | $2.37 M(-8.3%) | - |
| July 2014 | $2.58 M | - |
FAQ
- What is BioXcel Therapeutics annual total debt?
- What is the all time high annual total debt for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual total debt year-on-year change?
- What is BioXcel Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly total debt year-on-year change?
What is BioXcel Therapeutics annual total debt?
The current annual total debt of BTAI is $101.38 M
What is the all time high annual total debt for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual total debt is $101.38 M
What is BioXcel Therapeutics annual total debt year-on-year change?
Over the past year, BTAI annual total debt has changed by +$7.55 M (+8.04%)
What is BioXcel Therapeutics quarterly total debt?
The current quarterly total debt of BTAI is $104.97 M
What is the all time high quarterly total debt for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly total debt is $104.97 M
What is BioXcel Therapeutics quarterly total debt year-on-year change?
Over the past year, BTAI quarterly total debt has changed by +$5.35 M (+5.37%)